Moderna Inc (NAS:MRNA)
$ 128.32 2.65 (2.11%) Market Cap: 49.18 Bil Enterprise Value: 40.89 Bil PE Ratio: 0 PB Ratio: 3.83 GF Score: 68/100

Moderna Inc at Chardan Genetic Medicines Conference (Virtual) Transcript

Oct 05, 2020 / 06:00PM GMT
Release Date Price: $71.95 (+4.56%)
Yevgeniya Livshits
Chardan Capital Markets, LLC, Research Division - Senior Research Analyst

Hello, and apologies for the slight delay. It's now my pleasure to introduce our fireside chat guest, Dr. Stephen Hoge, President of Moderna.

So Stephen, thank you for joining us today. (Operator Instructions)

So to start off, Stephen, would you provide a brief couple of minutes of introductory comments on Moderna to frame for us where Moderna is today relative to where it was last year when you guys presented at our conference?

Stephen Hoge
Moderna, Inc. - President

Of course. Well, first of all, thank you for the opportunity to present and join you today. It feels like -- it may have only been a year on a calendar, but it feels like it's been a couple of decades in all of our experiences since I last had a chance to speak to the conference. I -- where to start? It's hard not to say the word COVID when talking about what's happened to Moderna over the last few years, but I'm going to try and make that my last sort of comment in the news of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot